Loading...
Loading...
ICCC| Name | Value |
|---|---|
| Revenues | 6,011.6M |
| Cost of Revenue | 4,428.0M |
| Gross Profit | 1,583.6M |
| Operating Expense | 2,158.4M |
| Operating I/L | -574.9M |
| Other Income/Expense | -125.5M |
| Interest Income | 0.0M |
| Pretax | -700.4M |
| Income Tax Expense | 1.3M |
| Net Income/Loss | -701.7M |
ImmuCell Corporation is an animal health company that develops, manufactures, and markets products to enhance the health and productivity of dairy and beef cattle. Its product line includes First Defense, a scours preventive product for newborn calves, Tri-Shield First Defense for the treatment of E. coli, coronavirus, and rotavirus, and the California Mastitis Test for detecting somatic cell counts in milk. The company also offers Dual-Force First Defense for the nutritional and feed supplement markets and is involved in developing Re-Tain, an intramammary treatment for subclinical mastitis in lactating dairy cows. ImmuCell sells its products through animal health distributors.
